Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascites.

Autor: Tomooka, Fumimasa1 (AUTHOR), Moriya, Kei1,2 (AUTHOR) moriyak@naramed-u.ac.jp, Kubo, Takahiro1 (AUTHOR), Shibamoto, Akihiko1 (AUTHOR), Suzuki, Jyunya1 (AUTHOR), Iwai, Satoshi1 (AUTHOR), Takeda, Soichi1 (AUTHOR), Fujimoto, Yuki1 (AUTHOR), Enomoto, Masahide1 (AUTHOR), Murata, Koji1 (AUTHOR), Tsuji, Yuki1 (AUTHOR), Fujinaga, Yukihisa1 (AUTHOR), Kitagawa, Koh1 (AUTHOR), Nishimura, Norihisa1 (AUTHOR), Takaya, Hiroaki1 (AUTHOR), Kaji, Kosuke1 (AUTHOR), Kawaratani, Hideto1 (AUTHOR), Namisaki, Tadashi1 (AUTHOR), Akahane, Takemi1 (AUTHOR), Mitoro, Akira1 (AUTHOR)
Zdroj: Portal Hypertension & Cirrhosis. Sep2023, Vol. 2 Issue 3, p109-114. 6p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje